Our fellow PRC at the University of Kentucky, the Rural Cancer Prevention Center, was featured in an important story on the challenges of tackling cancer in rural Kentucky on PBS’s NewsHour on Friday, March 26, 2016.
The Rural Cancer Prevention Center is credited with advancing cancer screening and education in some of the poorest regions of the state.
See the story here:
In PLOS ONE, Andrew Strasser, PhD, Co-Investigator on the UPenn PRC Skin Cancer Communication project, Daniel Romer, Ph.D, research director at the Annenberg Public Policy Center, and fellow researchers reported on the first naturalistic clinical trial which shows that graphic warning labels are more effective than text-only warnings in encouraging smokers to consider quitting and in educating them about smoking’s risks.
Dr. Strasser’s tobacco regulatory research program examines the impact of advertising, marketing and labeling on risk perceptions and tobacco product use, He has been project leader on 9 NIH/FDA funded projects and is currently an Associate Editor of Nicotine and Tobacco Research
UPenn PRC Director Karen Glanz, PhD, MPH, was a Keynote Speaker at the 3rd International Conference on UV and Skin Cancer Prevention in Melbourne Australia, Dec 7 – 11, 2015.
Speaking on the topic, “Effectiveness of Prevention on Melanoma and Non-Melanoma Reduction,” Dr. Glanz also was a panelist with Melanie Wakefield, PhD, of the Cancer Council, Victoria, Australia, and a consultant on the UPenn PRC Skin Cancer Prevention Communication Project, and Louisa Gordon, MPH, PhD, of Griffith University, NSW, Australia
On SiriusXM’s Knowledge@Wharton, Karen Glanz, PhD, MPH,UPenn PRC Director and Professor of Epidemiology, and Jason Riis, PhD, Marketing Lecturer at the Wharton School of the University of Pennsylvania, discussed how the World Health Organization came to its conclusions about a link between red & processed meats and colorectal cancer, how important it is to understand the measurements that were used, and how cancers and diseases other than colorectal cancer should be considered among the health risks.
Under the direction of Karen Glanz, PhD, MPH, and Tim Rebbeck, PhD, the UPenn PRC, the Cancer Prevention and Control Research Network, and the Penn Center for Excellence in Prostate Cancer Disparities presented the Prostate Cancer Evidence Academy at the University of Pennsylvania. Nearly 100 attendees, including researchers, policy makers, survivors, and advocates, as well as physicians and other health care-providers, gathered for a comprehensive symposium on prostate cancer prevention, control, awareness, and education.
Dr. Glanz, Director of the UPenn PRC, introduced the plenary sessions and keynote.
Linda Jacobs, PhD, RN, presented at a Survivorship/Advocacy session on the Medical and Psychosocial Effects of Cancer Treatment in Survivors. Dr. Jacobs discussed the shift in prostate cancer research from cure to long-term survivorship and long-term vs. late effects of treatment. She is a Co-Investigator for UPenn PRC SIP 15-001 Self-Management Education for Childhood Cancer Survivors.
A panel discussion, “Research to Policy: Improving Prostate Cancer Outcomes,” was moderated by Neha Vapiwala, MD, University of Pennsylvania, and included Lorelei Mucci, ScD, MPH, Epidemiology, Christopher Saigal, MD, Medical Decision Making, Justin Bekelman, MD, Research and Practice, and Michael Scott, Activism and Education.
Christopher J. Logothetis, MD, The University of Texas, MD Anderson Cancer Center
“Transitioning from a Prognostic to a Predictive Classification of Prostate Cancer”
Lorelei Mucci, ScD,MPH, Harvard, T.H. Chan School of Public Health, Harvard University
“Epidemiology of Prostate Cancer Risk and Progression”
Colonel Jim Williams, MS, Pennsylvania Prostate Cancer Coalition
“Men: The Silent Majority – Prostate Cancer Advocacy”